Status:
COMPLETED
Analgesic Effect of Resistance Training for Breast Cancer Survivors
Lead Sponsor:
Aalborg University
Collaborating Sponsors:
Danish Cancer Society
Danish Cancer Survivor and Late Effects Group
Conditions:
Breast Cancer
Surgery
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Persistent pain after treatment for breast cancer is a major clinical problem, affecting 25-60 % of the patients and is a source of considerable physical disability and psychological distress. Thus, t...
Detailed Description
Breast cancer is the most common cancer in women worldwide with more than a million new cases diagnosed every year \[1\]. Fortunately, due to better treatment options, the population of long-term surv...
Eligibility Criteria
Inclusion
- primary diagnosis of breast cancer (grades I-IIIA).
- adult women at least 18 years of age.
- having received breast cancer treatment (i.e. surgery and possible adjuvant chemo and/or radiotherapy) at least 18 months before the start of the study.
- self reported pain in the areas of the breast, shoulder, axilla, arm and/or side of body with an intensity of ≥ 3 on a numeric rating scale (0 = no pain, 10 = worst pain imaginable).
- no signs of cancer recurrence.
- reading, writing and speaking Danish.
Exclusion
- breast surgery for cosmetic reasons or prophylactic mastectomy.
- bilateral breast cancer.
- lymphedema.
- other chronic pain conditions (e.g., rheumatoid arthritis).
- previous diagnosis of fibromyalgia syndrome.
Key Trial Info
Start Date :
August 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04509284
Start Date
August 10 2020
End Date
September 23 2021
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Health Science and Technology, Aalborg University
Aalborg, Northern Jutland, Denmark, 9220